IP Verse

Breast Cancer Therapeutics

PatentPatent Analysis

EP2618833

IMBA INSTITUT FR MOLEKULARE BIOTECHNOLOGIE
Application Number
EP11758242A
Filing Date
Sep 22, 2011
Status
Revoked
Oct 18, 2019
Grant Date
May 2, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP4121512B1

Bibliography

The patent EP2618833B1 was granted to Imba Institut FR Molekulare Biotechnologie on May 2, 2018 following the initial filing on Sep 22, 2011 under the application number EP11758242A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

DEHMEL & BETTENHAUSEN PATENTANWALTE PARTMBBFeb 1, 2019ADMISSIBLE
PATENTANWALTE ISENBRUCK BOSL HORSCHLER PARTG MBBJan 28, 2019ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents